Evidence map›Paper›PMID 28877214›Full record

ArticlePloS one2017

Direct versus indirect actions of ghrelin on hypothalamic NPY neurons.

Hiroshi Hashiguchi, Zhenyu Sheng, Vanessa Routh, Volodymyr Gerzanich, J Marc Simard, Joseph Bryan

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Ghrelin Modulates Voltage-Gated CaMolecular pharmacology · 2024
    Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Ninjin'yoeito Targets Distinct CaFrontiers in nutrition · 2020
    Article
  12. Article
  13. Review
  14. Glucagon-Like Peptide-1 (GLP-1) and 5-Hydroxytryptamine 2c (5-HTInternational journal of molecular sciences · 2019
    Article
  15. Review
  16. Endocannabinoids in Body Weight Control.Pharmaceuticals (Basel, Switzerland) · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Hiroshi HashiguchiDepartment of Diabetes and Endocrinology, Kagoshima University Graduate School of Medicine and Dental Science, Kagoshima, Kagoshima, Japan.ORCID http://orcid.org/0000-0003-4563-0367
Zhenyu ShengDepartment of Pharmacology, Physiology and Neuroscience, Rutgers The State University of New Jersey, Newark, New Jersey, United States of America.
Vanessa RouthDepartment of Pharmacology, Physiology and Neuroscience, Rutgers The State University of New Jersey, Newark, New Jersey, United States of America.
Volodymyr GerzanichDepartment of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
J Marc SimardDepartment of Neurosurgery, University of Maryland School of Medicine, Baltimore, Maryland, United States of America.
Joseph BryanPacific Northwest Diabetes Research Institute, Seattle, Washington, United States of America.
Rutgers, The State University of New Jersey · USUniversity of Maryland, Baltimore · USKagoshima University · JPPacific Northwest Diabetes Research Institute · US

Funding

Spinal cord injury, progressive hemorrhagic necrosis and the NC(Ca-ATP) channelR01NS060801 · NINDS · UNIVERSITY OF MARYLAND BALTIMORE · PI SIMARD, J. MARC · 2009 to 2018
$3.3M
Challenging the Dominant Model for ATP Regulation of KATP ChannelsR01DK098647 · NIDDK · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI BRYAN, JOSEPH · 2014 to 2017
$1.4M
Role of neuropeptide Y-glucose inhibited (NPY-GI) neurons in cytokine-induced anoR21CA139063 · NCI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI ROUTH, VANESSA H · 2009 to 2010
$378k
Hypoglycemia and alpha cell regulationR56DK084242 · NIDDK · PACIFIC NORTHWEST RESEARCH INSTITUTE · PI BRYAN, JOSEPH · 2009 to 2009
$219k
NCI NIH HHS R21 CA139063NIDDK NIH HHS R01 DK098647NIDDK NIH HHS R56 DK084242NINDS NIH HHS R01 NS060801
6 · The paper itself

Abstract

objectivesAssess direct versus indirect action(s) of ghrelin on hypothalamic NPY neurons. MATERIALS AND

methodsElectrophysiology was used to measure ion channel activity in NPY-GFP neurons in slice preparations. Ca2+ imaging was used to monitor ghrelin activation of isolated NPY GFP-labeled neurons. Immunohistochemistry was used to localize Trpm4, SUR1 and Kir6.2 in the hypothalamus.

resultsAcylated ghrelin depolarized the membrane potential (MP) of NPY-GFP neurons in brain slices. Depolarization resulted from a decreased input resistance (IR) in ~70% of neurons (15/22) or an increased IR in the remainder (7/22), consistent with the opening or closing of ion channels, respectively. Although tetrodotoxin (TTX) blockade of presynaptic action potentials reduced ghrelin-induced changes in MP and IR, ghrelin still significantly depolarized the MP and decreased IR in TTX-treated neurons, suggesting that ghrelin directly opens cation channel(s) in NPY neurons. In isolated NPY-GFP neurons, ghrelin produced a sustained rise of [Ca2+]c, with an EC50 ~110 pM. Pharmacologic studies confirmed that the direct action of ghrelin was through occupation of the growth hormone secretagogue receptor, GHS-R, and demonstrated the importance of the adenylate cyclase/cAMP/protein kinase A (PKA) and phospholipase C/inositol triphosphate (PLC/IP3) pathways as activators of 5' AMP-activated protein kinase (AMPK). Activation of isolated neurons was not affected by CNQX or TTX, but reducing [Na+]o suppressed activation, suggesting a role for Na+-permeable cation channels. SUR1 and two channel partners, Kir6.2 and Trpm4, were identified immunologically in NPY-GFP neurons in situ. The actions of SUR1 and Trpm4 modulators were informative: like ghrelin, diazoxide, a SUR1 agonist, elevated [Ca2+]c and glibenclamide, a SUR1 antagonist, partially suppressed ghrelin action, while 9-phenanthrol and flufenamic acid, selective Trpm4 antagonists, blocked ghrelin actions on isolated neurons. Ghrelin activation was unaffected by nifedipine and ω-conotoxin, inhibitors of L- and N-type Ca2+ channels, respectively, while Ni2+, mibefradil, and TTA-P2 completely or partially inhibited ghrelin action, implicating T-type Ca2+ channels. Activation was also sensitive to a spider toxin, SNX-482, at concentrations selective for R-type Ca2+ channels. Nanomolar concentrations of GABA markedly inhibited ghrelin-activation of isolated NPY-GFP neurons, consistent with chronic suppression of ghrelin action in vivo.

conclusionsNPY neurons express all the molecular machinery needed to respond directly to ghrelin. Consistent with recent studies, ghrelin stimulates presynaptic inputs that activate NPY-GFP neurons in situ. Ghrelin can also directly activate a depolarizing conductance. Results with isolated NPY-GFP neurons suggest the ghrelin-activated, depolarizing current is a Na+ conductance with the pharmacologic properties of SUR1/Trpm4 non-selective cation channels. In the isolated neuron model, the opening of SUR1/Trpm4 channels activates T- and SNX482-sensitive R-type voltage dependent Ca2+ channels, which could contribute to NPY neuronal activity in situ.

Indexed as

AnimalsCalciumFluorescent Antibody TechniqueGhrelinHypothalamus, MiddleMaleMembrane PotentialsMiceNeuronsNeuropeptide YSignal TransductionCalciumGhrelinNeuropeptide Y

Identifiers

PMID28877214
PMCPMC5587286
OpenAlexW2751426053

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.